Clinical Trial Update: A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia [Phase 3]

View source ↗

Summary

Phase 3 study of Vatiquinone in Friedreich Ataxia is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Vatiquinone

Snippet

Sponsor: PTC Therapeutics | Conditions: Friedreich Ataxia | Phase 3 | Status: ACTIVE_NOT_RECRUITING